Specify a stock or a cryptocurrency in the search bar to get a summary
icad inc
ICADiCAD, Inc. engages in the provision of cancer detection and therapy solutions in the United States. It operates through two segments, Detection and Therapy. The company provides ProFound AI for digital breast tomosynthesis and 2D mammography; PowerLook, a density assessment solution; and ProFound Risk, a breast cancer risk analysis. The company was formerly known as Howtek, Inc. and changed its name to iCAD, Inc. in June 2002. iCAD, Inc. was incorporated in 1984 and is headquartered in Nashua, New Hampshire. Address: 98 Spit Brook Road, Nashua, NH, United States, 03062
Analytics
WallStreet Target Price
4.83 USDP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures ICAD
Dividend Analytics ICAD
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History ICAD
Stock Valuation ICAD
Financials ICAD
Results | 2019 | Dynamics |